<DOC>
	<DOCNO>NCT00858858</DOCNO>
	<brief_summary>This study two major goal : 1 . To determine effect bile salt cause DNA injury activate signal pathway promote growth cell esophagus patient gastroesophageal reflux disease ( GERD ) 2 . To determine whether change bile composition induce treat patient bile salt call ursodeoxycholic acid ( UDCA ) alter DNA injury , signal pathway activation type damage cell esophagus patient GERD .</brief_summary>
	<brief_title>Clinical Studies Bile Acids Barrett 's Esophagus</brief_title>
	<detailed_description>Patients schedule elective endoscopic examination Dallas VA Medical Center evaluation GERD Barrett 's esophagus invite participate study . Patients provide write , informed consent medical history take . Women child bear potential pregnancy test . Eligible subject treat omeprazole 20 mg BID least four week schedule endoscopic examination . Eight day endoscopy , patient instruct discontinue aspirin non-steroidal anti-inflammatory drug ( unless contraindication discontinue medication include history coronary artery disease , myocardial infarction , cerebrovascular accident transient ischemic attack ) . The endoscopic examination , schedule clinical purpose , perform usual , biopsy specimen take required clinical purpose . When clinical examination complete , perfusion catheter pass biopsy channel position 5 cm squamocolumnar junction distal esophagus . The distal esophagus perfuse 10cc 250 M solution either deoxycholic acid ( DCA ) ursodeoxycholic acid ( UDCA ) 5 minute . Odd-number patient enrol two patient group ( GERD patient without Barrett 's esophagus ) receive DCA , whereas even-number patient receive UDCA . The catheter position , bile acid concentration duration bile acid perfusion choose simulate typical episode gastroesophageal reflux . In patient , 12 biopsy specimen squamous epithelium take use jumbo biopsy forceps level 2 cm proximal squamocolumnar junction baseline ( 6 biopsy use establish primary cell culture six use molecular analysis ) ; 6 biopsy specimen take level immediately bile acid perfusion molecular analysis . In patient Barrett 's esophagus , 12 biopsy specimen specialize intestinal metaplasia also take use jumbo biopsy forceps level 1 cm distal squamocolumnar junction baseline ( 6 biopsy use establish primary cell culture six use molecular analysis ) ; 6 biopsy specimen take level immediately bile acid perfusion molecular analysis . All endoscopic procedure perform Dr. S.J . Spechler . All patient maintain omeprazole 20 mg BID one year , endoscopic examination repeat . The endoscopy perform bile acid perfusion biopsy sample exactly describe , except patient receive DCA first examination receive UDCA vice-versa . After second endoscopy , patient treat UDCA dose 10 mg/kg 8 week , final endoscopy perform . During endoscopy , DCA perfusion perform describe . In patient , 6 biopsy specimen squamous epithelium take use jumbo biopsy forceps level 2 cm proximal squamocolumnar junction baseline molecular analysis ; 6 biopsy specimen take level immediately bile acid perfusion molecular analysis . In patient Barrett 's esophagus , 6 biopsy specimen specialize intestinal metaplasia also take use jumbo biopsy forceps level 1 cm distal squamocolumnar junction baseline molecular analysis ; 6 biopsy specimen take level immediately bile acid perfusion molecular analysis .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Patients schedule elective endoscopic examination Dallas VA Medical Center evaluation GERD Barrett 's esophagus Patients unwilling unable provide inform consent Patients esophageal carcinoma Patients esophageal varix Patients take warfarin clopidogrel Coagulopathy preclude safe biopsy esophagus Comorbidity precludes safe participation study Allergy omeprazole UDCA Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>